Prentice Heather A, Lu Hailin, Price Matthew A, Kamali Anatoli, Karita Etienne, Lakhi Shabir, Sanders Eduard J, Anzala Omu, Allen Susan, Goepfert Paul A, Hunter Eric, Gilmour Jill, Tang Jianming
Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
International AIDS Vaccine Initiative, New York, New York, USA.
J Virol. 2016 Oct 28;90(22):10423-10430. doi: 10.1128/JVI.01467-16. Print 2016 Nov 15.
In individuals with HIV-1 infection, depletion of CD4 T cells is often accompanied by a malfunction of CD8 T cells that are persistently activated and/or exhausted. While the dynamics and correlates of CD4 counts have been well documented, the same does not apply to CD8 counts. Here, we examined the CD8 counts in a cohort of 497 Africans with primary HIV-1 infection evaluated in monthly to quarterly follow-up visits for up to 3 years in the absence of antiretroviral therapy. Statistical models revealed that (i) CD8 counts were relatively steady in the 3- to 36-month period of infection and similar between men and women; (ii) neither geography nor heterogeneity in the HIV-1 set-point viral load could account for the roughly 10-fold range of CD8 counts in the cohort (P > 0.25 in all tests); and (iii) factors independently associated with relatively high CD8 counts included demographics (age ≤ 40 years, adjusted P = 0.010) and several human leukocyte antigen class I (HLA-I) alleles, including HLA-A03:01 (P = 0.013), B15:10 (P = 0.007), and B*58:02 (P < 0.001). Multiple sensitivity analyses provided supporting evidence for these novel relationships. Overall, these findings suggest that factors associated with the CD8 count have little overlap with those previously reported for other HIV-1-related outcome measures, including viral load, CD4 count, and CD4/CD8 ratio.
Longitudinal data from 497 HIV-1 seroconverters allowed us to systematically evaluate the dynamics and correlates of CD8 T-cell counts during untreated primary HIV-1 infection in eastern and southern Africans. Our findings suggest that individuals with certain HLA-I alleles, including A03 (exclusively A03:01), persistently maintain relatively high CD8 counts following HIV-1 infection, a finding which may offer an intriguing explanation for the recently reported, negative association of A*03 with HIV-1-specific, broadly neutralizing antibody responses. In future studies, attention to HLA-I genotyping data may benefit in-depth understanding of both cellular and humoral immunity, as well as the intrinsic balances of these types of immunity, especially in settings where there is emerging evidence of antagonism between the two arms of adaptive immunity.
在HIV-1感染者中,CD4 T细胞耗竭常伴有持续激活和/或耗竭的CD8 T细胞功能异常。虽然CD4细胞计数的动态变化及其相关因素已有充分记录,但CD8细胞计数并非如此。在此,我们对497名原发性HIV-1感染的非洲人队列中的CD8细胞计数进行了研究,这些人在未接受抗逆转录病毒治疗的情况下,接受了每月至每季度一次的随访,最长达3年。统计模型显示:(i)在感染的3至36个月期间,CD8细胞计数相对稳定,且男女之间相似;(ii)HIV-1设定点病毒载量的地理因素和异质性均无法解释该队列中CD8细胞计数约10倍的范围(所有测试中P>0.25);(iii)与相对较高CD8细胞计数独立相关的因素包括人口统计学因素(年龄≤40岁,校正后P = 0.010)和几种人类白细胞抗原I类(HLA-I)等位基因,包括HLA-A03:01(P = 0.013)、B15:10(P = 0.007)和B*58:02(P<0.001)。多项敏感性分析为这些新关系提供了支持性证据。总体而言,这些发现表明,与CD8细胞计数相关的因素与先前报道的其他HIV-1相关结局指标(包括病毒载量、CD4细胞计数和CD4/CD8比值)几乎没有重叠。
来自497名HIV-1血清转化者的纵向数据使我们能够系统地评估东非和南非未治疗的原发性HIV-1感染期间CD8 T细胞计数的动态变化及其相关因素。我们的研究结果表明,具有某些HLA-I等位基因(包括A03(仅A03:01))的个体在HIV-1感染后持续保持相对较高的CD8细胞计数,这一发现可能为最近报道的A*03与HIV-1特异性广泛中和抗体反应之间的负相关提供一个有趣的解释。在未来的研究中,关注HLA-I基因分型数据可能有助于深入了解细胞免疫和体液免疫,以及这些免疫类型的内在平衡,特别是在有新证据表明适应性免疫的两个分支之间存在拮抗作用的情况下。